SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

Traders are focused on Starknets post-quantum security work, including reported quantum-resistant transaction tests, alongside privacy features and Bitcoin DeFi; some also cite the longer-term possibility of an independent L1. Supporters see these developments as differentiators, while others remain bearish amid STRKs price weakness and concerns about token supply.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics quarterly updateshowing stronger Eversense CGM adoption and raised full-year guidanceis a key focus, with bulls citing commercial momentum and future pump integrations. The debate is tempered by concerns about heavy cash burn, possible dilution, and whether sales, insurance coverage, and distribution can scale quickly enough.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklos steep selloff is being blamed by traders largely on ongoing share dilution from its stock-sale program, alongside concerns that the pre-revenue reactor business faces a long path to deployment. Bears question the companys execution and valuation, while some investors see the decline as an oversold buying opportunity tied to long-term nuclear power demand and potential regulatory or customer milestones.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta Personals rollout and its fiat-payment features, alongside partnerships tied to Visa Direct and the ASK Groups planned tokenization venture, are fueling attention. Bulls see these as potential drivers of real network use, while skeptics say adoption and on-chain volume remain unproven and the price has struggled to sustain gains.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

XBI is drawing attention amid a broad biotech pullback, with traders attributing weakness to rate and macro concerns, risk-off trading, and rotation away from smaller-cap biotech. The community is divided between expecting further downside and viewing the selloff as an oversold correction and buying opportunity, with some also citing hoped-for M&A as a potential sector catalyst.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

CCXI is drawing attention as a SPAC vehicle for a proposed merger with Agility Robotics, giving investors a speculative way to bet on humanoid robotics and the companys commercial deployments and strategic backers. Bullish traders see potential in the robotics theme and reported institutional interest, while skeptics point to Agilitys early-stage finances, valuation, and the risk of a post-merger SPAC selloff.

Aventus Network

AVT is drawing attention for a volatile rebound and renewed trading activity in a thinly traded, low-float token, with traders debating a possible breakout or squeeze versus persistent selling and concentrated ownership. Aventus Clouds decentralized-compute and enterprise-appchain updates add a bullish project narrative, while the earlier exploit-related selloff remains a source of caution.

Devon Energy Corp. engages in the exploration, development, and production of oil and natural gas properties. It develops and operates Delaware Basin, Eagle Ford, Heavy Oil, Barnett Shale, STACK, and Rockies Oil. The company was founded by J. Larry Nichols and John W. Nichols in 1971 and is headquartered in Oklahoma City, OK.

Devon Energy Corp.

Devons agreed sale of its Eagle Ford assets to Crescent Energy is the main catalyst, confirming earlier divestiture speculation and signaling a portfolio exit. Traders see the cash sale as a potential step toward simplifying the business, but some question why the stock has not responded more strongly amid mixed oil-price moves.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Attention centers on TG Therapeutics scheduled MSToronto presentations, especially initial Phase 1 azer-cel results in progressive MS, alongside BRIUMVI data and the anticipated subcutaneous Phase 3 readout. Many traders are optimistic about the pipeline and BRIUMVIs commercial prospects, while others caution that early azer-cel findings are limited; buyout talk remains speculation.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is drawing attention amid a sharp software-sector pullback, with traders pointing to AI-funding concerns weighing on DDOG and peers. Some see no clear company-specific trigger, while valuation remains a recurring bearish concern.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

VIGN Vignette Corporation

Latest VIGN News